Sardine oil loaded vanillic acid grafted chitosan microparticles improves the in vivo antioxidant, haematological and lipid profile.

Unlabelled: Oxidative stability of fish oil supplements poses a considerable health risk which can be prevented by novel delivery systems. A newly developed formulation of microencapsulated sardine oil showed excellent oxidative stability in vitro. The present study's objective is to evaluate the new formulation in vivo as a potential new supplement which may improve antioxidant, haematological, and lipid profile. The optimisation of the sardine oil loaded microparticles (SO-M) and the characterisation have been presented briefly. The SO-M formulation was fed to male albino rats for two months. Following the feeding experiment, haemoglobin content, platelet and RBC count were assessed in the control and treated group. Similarly, levels of serum cholesterol, HDL, LDL, triglycerides, and metabolic enzyme biomarkers, namely catalase, SOD, GST, AST, ALT, ACP and ALP, were compared. The blood analysis showed a significant increase in haemoglobin, platelets and RBC count in the treated group. Lipid profiling showed that both triglycerides and LDL levels were decreased in the sample treated group. This study also showed significant modulation of antioxidant enzymes such as catalase, SOD and GST. The new formulation of PUFA rich sardine oil significantly improved the in vivo antioxidant, haematological and lipid profile, suggesting potential use as a dietary supplement.

Supplementary Information: The online version contains supplementary material available at 10.1007/s13197-021-05329-5.